ATE216575T1 - Treibgasmischung für eine aerosolzubereitung - Google Patents
Treibgasmischung für eine aerosolzubereitungInfo
- Publication number
- ATE216575T1 ATE216575T1 AT95941077T AT95941077T ATE216575T1 AT E216575 T1 ATE216575 T1 AT E216575T1 AT 95941077 T AT95941077 T AT 95941077T AT 95941077 T AT95941077 T AT 95941077T AT E216575 T1 ATE216575 T1 AT E216575T1
- Authority
- AT
- Austria
- Prior art keywords
- gas mixture
- propellant gas
- aerosol preparation
- propellant
- inhalation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/30—Materials not provided for elsewhere for aerosols
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9425160.0A GB9425160D0 (en) | 1994-12-10 | 1994-12-10 | Medicaments |
PCT/EP1995/004824 WO1996018384A1 (en) | 1994-12-10 | 1995-12-08 | Propellant mixture for aerosol formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE216575T1 true ATE216575T1 (de) | 2002-05-15 |
Family
ID=10765889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95941077T ATE216575T1 (de) | 1994-12-10 | 1995-12-08 | Treibgasmischung für eine aerosolzubereitung |
Country Status (9)
Country | Link |
---|---|
US (2) | US6153173A (de) |
EP (1) | EP0789557B1 (de) |
JP (1) | JPH10510521A (de) |
AT (1) | ATE216575T1 (de) |
AU (1) | AU4260496A (de) |
DE (1) | DE69526517T2 (de) |
ES (1) | ES2174970T3 (de) |
GB (1) | GB9425160D0 (de) |
WO (1) | WO1996018384A1 (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270305A (en) * | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
DE4003270A1 (de) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgase und ihre verwendung in arzneimittelzubereitungen |
WO1993011201A1 (en) * | 1991-12-03 | 1993-06-10 | United States Environmental Protection Agency | Refrigerant compositions and processes for using same |
US20030103907A1 (en) * | 1991-12-18 | 2003-06-05 | Schultz Robert K. | Suspension aerosol formulations |
US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
ATE150296T1 (de) * | 1991-12-18 | 1997-04-15 | Minnesota Mining & Mfg | Aerosolzusammensetzungen für arzneimittelsuspensionen |
US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
US6932962B1 (en) * | 1994-12-22 | 2005-08-23 | Astrazeneca Ab | Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides |
GB9612297D0 (en) * | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
US6054488A (en) * | 1996-06-11 | 2000-04-25 | 3M Innovative Properties Company | Medicinal aerosol formulations of formoterol |
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
GB9620187D0 (en) † | 1996-09-27 | 1996-11-13 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
US6039932A (en) * | 1996-09-27 | 2000-03-21 | 3M Innovative Properties Company | Medicinal inhalation aerosol formulations containing budesonide |
AU6181098A (en) * | 1997-02-24 | 1998-09-09 | Allied-Signal Inc. | Azeotrope-like compositions of pentafluoropropane and tetrafluoroethane |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
GB2332372B (en) * | 1997-12-08 | 2002-08-14 | Minnesota Mining & Mfg | Pharmaceutical aerosol compositions |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
US6423298B2 (en) | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
US6458338B1 (en) * | 1998-09-22 | 2002-10-01 | Aeropharm Technology Incorporated | Amino acid stabilized medicinal aerosol formulations |
US6235265B1 (en) | 1998-10-28 | 2001-05-22 | Alliedsignal Inc. | Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
ES2193069T3 (es) * | 1999-04-14 | 2003-11-01 | Glaxo Group Ltd | Formulacion farmaceutica en aerosol. |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
GB9918626D0 (en) * | 1999-08-07 | 1999-10-13 | Glaxo Group Ltd | Valve |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
DE60035904T2 (de) * | 2000-05-11 | 2008-05-08 | Alliedsignal Inc. | Fluorkohlenwasserstoffe enthaltender verdampfungskühler |
UA73986C2 (uk) | 2000-05-22 | 2005-10-17 | К'Єзі Фармачеутічі С.П.А. | АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
US6455028B1 (en) | 2001-04-23 | 2002-09-24 | Pharmascience | Ipratropium formulation for pulmonary inhalation |
ATE267591T1 (de) | 2001-07-02 | 2004-06-15 | Chiesi Farma Spa | Optimierte tobramycin-formulierung zur aerosolbildung |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
US20030060422A1 (en) | 2001-08-31 | 2003-03-27 | Balaji Venkataraman | Tannate compositions and methods of treatment |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US6702997B2 (en) | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030140920A1 (en) * | 2001-10-26 | 2003-07-31 | Dey L.P. | Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
JP4933046B2 (ja) | 2002-09-06 | 2012-05-16 | フィリップ モーリス ユーエスエー インコーポレイテッド | 液体エアロゾル製剤、エアロゾル発生装置およびエアロゾル発生方法 |
EP1556171B1 (de) * | 2002-09-06 | 2010-12-15 | Philip Morris USA Inc. | Aerosolerzeugungsvorrichtungen und verfahren zur erzeugung von aerosolen mit gesteuerten teilchengrössen |
AU2003293361A1 (en) * | 2002-12-18 | 2004-07-29 | Glaxo Group Limited | Drug delivery system with vented mouthpiece |
US20040223918A1 (en) * | 2003-05-07 | 2004-11-11 | Chrysalis Technologies Incorporated | Aerosolization of cromolyn sodium using a capillary aerosol generator |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
EP1595531A1 (de) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stabile Arzneimittellösung für Druckdosierinhalatoren |
US20050238632A1 (en) * | 2004-04-23 | 2005-10-27 | Alburty David S | Propellant formulations |
CA2567334A1 (en) * | 2004-05-20 | 2005-12-08 | Discovery Laboratories, Inc. | Methods , systems and devices for noninvasive pulmonary delivery |
US8028697B2 (en) | 2005-04-28 | 2011-10-04 | Trudell Medical International | Ventilator circuit and method for the use thereof |
US20070039635A1 (en) * | 2005-08-19 | 2007-02-22 | Honeywell International Inc. | Gas jet apparatus and method |
KR20090129998A (ko) | 2007-02-11 | 2009-12-17 | 맵 파마슈티컬스, 인코포레이티드 | 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 dhe의 치료적 투여 방법 |
MX2010010139A (es) | 2008-03-17 | 2011-02-21 | Discovery Lab Inc | Adaptador de circuito de ventilacion y sistema proximo de suministro en aerosol. |
EP2626098B1 (de) | 2008-10-22 | 2020-08-19 | Trudell Medical International | Modulares Aerosolabgabesystem |
CN111297802A (zh) * | 2018-12-12 | 2020-06-19 | 成都一平医药科技发展有限公司 | 一种用于抗炎及抗菌的组合物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0965335B1 (de) * | 1990-03-23 | 2003-09-17 | Minnesota Mining And Manufacturing Company | Aerosolzubereitungen zur dosierten Abgabe |
US5118494A (en) * | 1990-03-23 | 1992-06-02 | Minnesota Mining And Manufacturing Company | Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
US5474759A (en) * | 1991-06-10 | 1995-12-12 | Schering Corporation | Non-chlorofluorocarbon aerosol formulations |
AU2343692A (en) * | 1991-07-22 | 1993-02-23 | E.I. Du Pont De Nemours And Company | Uses of 1,2,2,3,3-pentafluoropropane |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
US5674471A (en) * | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
WO1993011745A1 (en) * | 1991-12-12 | 1993-06-24 | Glaxo Group Limited | Medicaments |
DE4230876A1 (de) * | 1992-03-17 | 1993-09-23 | Asta Medica Ag | Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten |
US5376359A (en) * | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
MX9304585A (es) * | 1992-07-31 | 1994-03-31 | Glaxo Group Ltd | Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata. |
US5278196A (en) * | 1993-03-25 | 1994-01-11 | Great Lakes Chemical Corp. | Hydrofluorocarbon compositions as blowing agents for cellular plastics |
DK0735884T3 (da) * | 1993-12-20 | 2000-10-09 | Minnesota Mining & Mfg | Flunisolid-aerosolformuleringer |
US6039932A (en) * | 1996-09-27 | 2000-03-21 | 3M Innovative Properties Company | Medicinal inhalation aerosol formulations containing budesonide |
-
1994
- 1994-12-10 GB GBGB9425160.0A patent/GB9425160D0/en active Pending
-
1995
- 1995-12-08 DE DE69526517T patent/DE69526517T2/de not_active Expired - Fee Related
- 1995-12-08 WO PCT/EP1995/004824 patent/WO1996018384A1/en active IP Right Grant
- 1995-12-08 AU AU42604/96A patent/AU4260496A/en not_active Abandoned
- 1995-12-08 EP EP95941077A patent/EP0789557B1/de not_active Expired - Lifetime
- 1995-12-08 US US08/849,217 patent/US6153173A/en not_active Expired - Fee Related
- 1995-12-08 ES ES95941077T patent/ES2174970T3/es not_active Expired - Lifetime
- 1995-12-08 JP JP8518236A patent/JPH10510521A/ja active Pending
- 1995-12-08 AT AT95941077T patent/ATE216575T1/de not_active IP Right Cessation
-
2000
- 2000-08-29 US US09/650,283 patent/US6309624B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH10510521A (ja) | 1998-10-13 |
GB9425160D0 (en) | 1995-02-08 |
DE69526517D1 (de) | 2002-05-29 |
US6153173A (en) | 2000-11-28 |
WO1996018384A1 (en) | 1996-06-20 |
EP0789557B1 (de) | 2002-04-24 |
DE69526517T2 (de) | 2002-10-31 |
US6309624B1 (en) | 2001-10-30 |
ES2174970T3 (es) | 2002-11-16 |
AU4260496A (en) | 1996-07-03 |
EP0789557A1 (de) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE216575T1 (de) | Treibgasmischung für eine aerosolzubereitung | |
DK0799024T3 (da) | Farmaceutisk aerosol indeholdende mindst en sukker | |
MY109758A (en) | Aerosol formulations of use for the administration of medicaments by inhalation | |
DK0616525T3 (da) | Medikamenter | |
PH27594A (en) | Medicaments for the treatment of asthma and other respiratory disorders | |
DK0656207T4 (da) | Aerosolformuleringer uden chlorfluorcarbonforbindelser | |
EA200100338A1 (ru) | Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента | |
MY108748A (en) | Medicaments | |
CA2125666A1 (en) | Medicaments | |
BR9712125A (pt) | Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente | |
HUP0101608A2 (hu) | Aeroszol formájú gyógyszerkészítmény és eljárás előállítására | |
BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
TH13643EX (th) | สูตรผสมรูปแบบละอองลอยทางเภสัชกรรมซึ่งมีสารรักษาโรคและตัวผลักดันชนิดไฮโดรฟลูโอโรคาร์บอน | |
MY111155A (en) | Medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |